TIMI IIIA
OBJECTIVE: To evaluate the effect of rtPA vs. placebo on the culprit coronary lesion in patients with unstable angina or non-Q-wave myocardial infarction.
View/Download
_______________________________________________________________________________
-
Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest. Results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trial. Circulation 1993;87:38-52.
| Abstract | Request Reprint |
-
Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA Trial). Diver DJ, Bier JD, Ferreira PE, et al. Am J Cardiol 1994;74:531-7
| Abstract | Request Reprint | .
-
Characterization of patient management and outcome in the TIMI-IIIA trial. Diver DJ, Brown BG, Breall JA, Berger C, Dunn S, Thompson B, McCabe CH, Braunwald E, and the TIMI-III Study Group. J Am Coll Cardiol 1994;Special Issue:289A.
|
